Washington, D.C. – The Medical Imaging & Technology Alliance (MITA), the leading organization and collective voice of medical imaging equipment, radiopharmaceutical, contrast media, and focused ultrasound device manufacturers, today applauded the Centers for Medicare & Medicaid Services (CMS) for its recently issued final rule concerning the Medicare Coverage of Innovative Technology (MCIT) program. As finalized, the rule will reduce the lag between Food and Drug Administration (FDA) marketing authorization and subsequent Medicare coverage for innovative medical devices.
"The MCIT final rule is a major regulatory win – not only for MITA, which has actively advocated for swifter market access policies, but also for countless American patients who will now have expanded access to innovative, FDA-authorized medical solutions that would otherwise be left in limbo," said Patrick Hope, Executive Director of MITA.
Specifically, the final rule creates a Medicare coverage pathway that expedites patient access to innovative medical devices with FDA "breakthrough" designation. As finalized, the rulemaking grants a drug or device designated by the FDA as "breakthrough" with immediate, four-year Medicare coverage.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Before the rule's finalization, MITA submitted comments supporting the Agency's proposed changes to the MCIT program, which were announced in September of 2020. Along with a formal comment letter, MITA joined the Focused Ultrasound (FUS) Foundation to publicly urge the Agency to create the new Medicare coverage pathway.
"As CMS works to implement this important policy update in the final days of the current Administration, we strongly urge President-elect Biden and his health team to uphold this change and continue on the path towards greater patient access to these innovative medical solutions," Hope concluded.
The Medical Imaging & Technology Alliance (MITA), a division of NEMA, is the collective voice of medical imaging equipment manufacturers, innovators, and product developers. It represents companies whose sales comprise more than 90 percent of the global market for advanced medical imaging technology. For more information, visit www.medicalimaging.org. Follow MITA on Twitter @MITAToday.